Kanagawa, Japan

Kiyoshi Oizumi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kiyoshi Oizumi: Innovator in Osteogenesis-Promoting Compounds

Introduction

Kiyoshi Oizumi is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that promote osteogenesis. With a total of 2 patents, Oizumi's work is recognized for its potential impact on medical treatments related to bone health.

Latest Patents

Oizumi's latest patents include innovative cyclic compounds. The first patent describes a cyclic compound having a hetero atom, which exhibits an osteogenesis-promoting action and is represented by a specific general formula or a pharmacologically acceptable salt thereof. The second patent focuses on a cyclic compound with a substituted phenyl group, which is also a low molecular weight compound exhibiting osteogenesis-promoting action, again defined by a general formula or a pharmacologically acceptable salt.

Career Highlights

Kiyoshi Oizumi is currently associated with Daiichi Sankyo Company, Limited, a prominent player in the pharmaceutical industry. His work at the company has allowed him to explore and develop innovative solutions in the realm of bone health.

Collaborations

Oizumi has collaborated with esteemed colleagues such as Osamu Kanno and Katsuyoshi Nakajima. Their combined expertise has contributed to the advancement of research in osteogenesis-promoting compounds.

Conclusion

Kiyoshi Oizumi's contributions to the field of pharmacology, particularly through his patents, highlight his role as an innovator in developing compounds that promote bone health. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…